打开封闭的入口 - - 探索左冠心病治疗方案:一个案例报告
Yoshihiro Imai1, Atsushi Hirohata2, Hirofumi Nakajima3
1Department of Cardiology, Nakashima Hospital, 122 Tamachi, Tsuyama, Okayama 7080052, Japan.
European heart journal. Case reports
|March 9, 2026
概括
使用外侧阴动脉自移植的手术重建为治疗罕见的左主冠状动脉缩提供了一个有希望的替代方案. 这种创新方法可能会为这种复杂的先天异常提供比传统的绕道手术更好的结果.
科学领域:
- 心血管外科心血管外科
- 遗传性心脏病是一种先天性心脏病.
- 血管重建 血管重建
背景情况:
- 左主冠状动脉 (LMCA) 缺动是一种罕见的先天性异常,治疗数据有限.
- 临床表现范围从心痛和昏迷到突然死亡.
- 传统的绕道移植对LMCA形的长期结果是不确定的.
研究的目的:
- 报告第一个使用外部阴动脉 (EIA) 自体移植的LMCA形的外科重建.
- 要突出缺血检测在先天性冠状动脉异常的局限性.
- 讨论重建的潜在优势,而不是传统的绕道手术.
主要方法:
- 一名37岁的女性确诊LMCA缩经历了手术重建.
- 一个外部阴动脉自移植被用来连接大动脉到LMCA.
- 用血管假肢修复了EIA收获地点.
主要成果:
- 患者没有出现并发症而康复,并且在医学治疗下临床稳定.
- 这项研究表明,对LMCA缩的EIA自移植重建的可行性.
- 这一案例强调了先天性冠状动脉异常中缺血检测的挑战.
结论:
- 外侧阴动脉自移植重建是LMCA缩的潜在有效的外科选择.
- 在本地流的病例中,重建可能比常规绕道提供优势.
- 个性化治疗决策对于管理这种罕见的疾病至关重要.
相关概念视频
Coronary Artery Disease V: Interprofessional Care
357
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
357
Acute Coronary Syndrome IV: Interprofessional Care
363
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
363
Acute Coronary Syndrome III: Diagnostic Studies
357
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
357
Angina IV: Management
372
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
372
Coronary Artery Disease IV: Preventive Measures
789
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
789
Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K


